Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Patient Reported Outcomes (PROs) indicate Linvoseltamab Improves QOL | Joshua Richter, MD | #IMS25
HealthTreeDescription
Dr. Joshua Richter discusses long-term follow-up data showing that linvoseltamab not only delivers durable responses but also improves fatigue, pain, and overall quality of life for myeloma patients.
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.